dihydroxyphenylalanine has been researched along with Prodromal Characteristics in 4 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS | 1 |
| Holmes, C | 1 |
| Lopez, GJ | 1 |
| Wu, T | 1 |
| Sharabi, Y | 1 |
| Allen, P | 2 |
| Luigjes, J | 1 |
| Howes, OD | 3 |
| Egerton, A | 2 |
| Hirao, K | 1 |
| Valli, I | 1 |
| Kambeitz, J | 1 |
| Fusar-Poli, P | 1 |
| Broome, M | 1 |
| McGuire, P | 2 |
| Roiser, JP | 1 |
| Chaddock, CA | 2 |
| Joyce, EM | 1 |
| Winton-Brown, TT | 1 |
| Bloomfield, MA | 1 |
| Bhattacharyya, S | 1 |
| McGuire, PK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis[NCT05282277] | Phase 4 | 103 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for dihydroxyphenylalanine and Prodromal Characteristics
| Article | Year |
|---|---|
Cardiac sympathetic denervation predicts PD in at-risk individuals.
Topics: Aged; Biomarkers; Dihydroxyphenylalanine; Female; Heart Septum; Heart Ventricles; Humans; Male; Midd | 2018 |
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.
Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Dihydroxyphenylalanine; Disease Progression; Fema | 2012 |
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.
Topics: Adult; Basal Ganglia; Cerebrum; Delusions; Dihydroxyphenylalanine; Dopamine; Female; Functional Neur | 2013 |
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Topics: Adult; Basal Ganglia; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hum | 2013 |